Novavax (NVAX)
(Real Time Quote from BATS)
$12.88 USD
-0.03 (-0.23%)
Updated Sep 23, 2024 02:46 PM ET
3-Hold of 5 3
D Value A Growth D Momentum C VGM
Cash flow Statements
Fiscal Year End for Novavax, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -545.06 | -657.94 | -1,743.75 | -418.26 | -132.69 |
Depreciation/Amortization & Depletion | 41.23 | 29.05 | 12.66 | 6.31 | 7.10 |
Net Change from Assets/Liabilities | -376.84 | -361.15 | 1,733.62 | 12.02 | -24.02 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 166.71 | 574.10 | 320.42 | 357.39 | 12.99 |
Net Cash From Operating Activities | -713.97 | -415.94 | 322.95 | -42.54 | -136.62 |
Property & Equipment | -53.77 | -89.06 | -57.49 | -54.62 | -1.86 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | -165.52 | 18.33 |
Investments | 0.00 | 0.00 | 157.64 | -157.64 | 22.02 |
Other Investing Activities | -5.04 | -3.93 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | -58.81 | -92.99 | 100.15 | -377.78 | 38.49 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 360.40 | 248.59 | 589.62 | 1,080.83 | 98.38 |
Issuance (Repayment) of Debt | -352.35 | 81.66 | -127.91 | -96.07 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -3.59 | -5.26 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | 4.47 | 324.99 | 461.71 | 984.76 | 98.38 |
Effect of Exchange Rate Changes | 3.27 | 4.52 | -5.29 | 2.12 | -0.03 |
Net Change In Cash & Equivalents | -765.04 | -179.41 | 879.52 | 566.56 | 0.22 |
Cash at Beginning of Period | 1,348.85 | 1,528.26 | 648.74 | 82.18 | 81.96 |
Cash at End of Period | 583.81 | 1,348.85 | 1,528.26 | 648.74 | 82.18 |
Diluted Net EPS | -5.41 | -8.42 | -23.44 | -7.27 | -5.51 |
Fiscal Year End for Novavax, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | 14.83 | -147.55 | -545.06 | -366.67 | -235.90 |
Depreciation/Amortization & Depletion | 23.28 | 12.15 | 41.23 | 30.43 | 19.11 |
Net Change from Assets/Liabilities | 149.50 | 34.26 | -376.84 | -327.24 | -371.22 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 43.11 | 17.58 | 166.71 | 126.30 | 90.48 |
Net Cash From Operating Activities | 230.71 | -83.56 | -713.97 | -537.19 | -497.53 |
Property & Equipment | -9.75 | -6.88 | -53.77 | -44.93 | -26.77 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | -369.58 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | -0.62 | -0.37 | -5.04 | -4.80 | -4.56 |
Net Cash from Investing Activities | -379.96 | -7.25 | -58.81 | -49.73 | -31.34 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 264.83 | 6.25 | 360.40 | 257.69 | 62.33 |
Issuance (Repayment) of Debt | -0.73 | -0.36 | -352.35 | -350.03 | -355.38 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.00 | 0.00 | -3.59 | -3.59 | 0.00 |
Net Cash from Financing Activities | 264.10 | 5.89 | 4.47 | -95.92 | -293.04 |
Effect of Exchange Rate Changes | -3.11 | -2.96 | 3.27 | 0.36 | -8.99 |
Net Change In Cash & Equivalents | 111.75 | -87.87 | -765.04 | -682.48 | -830.90 |
Cash at Beginning of Period | 583.81 | 583.81 | 1,348.85 | 1,348.85 | 1,348.85 |
Cash at End of Period | 695.56 | 495.94 | 583.81 | 666.36 | 517.94 |
Diluted Net EPS | 0.99 | -1.05 | -1.32 | -1.26 | 0.58 |